Skip to main content
Premium Trial:

Request an Annual Quote

Investment Bank Upgrades Invitrogen Stock; Shares Climb 3.6 Percent

NEW YORK, June 9 (GenomeWeb News) - Invitrogen's shares were up 3.6 percent, or $2.29, at $65.37 in mid-afternoon trading after Bears Sterns upgraded the company's stock to "Outperform" from "Peer Perform" today.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.